nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—ABCB1—Methylprednisolone—multiple sclerosis	0.0992	0.19	CbGbCtD
Candesartan—ABCB1—Mitoxantrone—multiple sclerosis	0.0724	0.139	CbGbCtD
Candesartan—ABCB1—Betamethasone—multiple sclerosis	0.0645	0.124	CbGbCtD
Candesartan—ABCB1—Prednisolone—multiple sclerosis	0.0637	0.122	CbGbCtD
Candesartan—ABCB1—Prednisone—multiple sclerosis	0.0601	0.115	CbGbCtD
Candesartan—CYP2C8—Dexamethasone—multiple sclerosis	0.0555	0.106	CbGbCtD
Candesartan—CYP2C9—Dexamethasone—multiple sclerosis	0.0387	0.0741	CbGbCtD
Candesartan—ABCB1—Dexamethasone—multiple sclerosis	0.0375	0.0719	CbGbCtD
Candesartan—ABCB1—Methotrexate—multiple sclerosis	0.0302	0.0578	CbGbCtD
Candesartan—Pranlukast—TNF—multiple sclerosis	0.00384	0.661	CrCbGaD
Candesartan—Valsartan—ALB—multiple sclerosis	0.00132	0.228	CrCbGaD
Candesartan—Haemorrhage—Triamcinolone—multiple sclerosis	0.000819	0.00245	CcSEcCtD
Candesartan—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000817	0.00244	CcSEcCtD
Candesartan—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000816	0.00244	CcSEcCtD
Candesartan—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000816	0.00244	CcSEcCtD
Candesartan—Hypertension—Mitoxantrone—multiple sclerosis	0.000816	0.00244	CcSEcCtD
Candesartan—Pharyngitis—Triamcinolone—multiple sclerosis	0.000813	0.00243	CcSEcCtD
Candesartan—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000811	0.00243	CcSEcCtD
Candesartan—Myocardial infarction—Betamethasone—multiple sclerosis	0.000811	0.00243	CcSEcCtD
Candesartan—Myalgia—Mitoxantrone—multiple sclerosis	0.000804	0.00241	CcSEcCtD
Candesartan—Chest pain—Mitoxantrone—multiple sclerosis	0.000804	0.00241	CcSEcCtD
Candesartan—Arthralgia—Mitoxantrone—multiple sclerosis	0.000804	0.00241	CcSEcCtD
Candesartan—Diarrhoea—Cladribine—multiple sclerosis	0.000803	0.0024	CcSEcCtD
Candesartan—Anxiety—Mitoxantrone—multiple sclerosis	0.000802	0.0024	CcSEcCtD
Candesartan—Sweating increased—Prednisone—multiple sclerosis	0.000787	0.00236	CcSEcCtD
Candesartan—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00078	0.00233	CcSEcCtD
Candesartan—Dizziness—Cladribine—multiple sclerosis	0.000776	0.00232	CcSEcCtD
Candesartan—Neutropenia—Prednisone—multiple sclerosis	0.000756	0.00226	CcSEcCtD
Candesartan—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000755	0.00226	CcSEcCtD
Candesartan—Abdominal pain—Azathioprine—multiple sclerosis	0.000754	0.00226	CcSEcCtD
Candesartan—Body temperature increased—Azathioprine—multiple sclerosis	0.000754	0.00226	CcSEcCtD
Candesartan—Tachycardia—Mitoxantrone—multiple sclerosis	0.000753	0.00225	CcSEcCtD
Candesartan—Haemoglobin—Dexamethasone—multiple sclerosis	0.000747	0.00223	CcSEcCtD
Candesartan—Haemoglobin—Betamethasone—multiple sclerosis	0.000747	0.00223	CcSEcCtD
Candesartan—Vomiting—Cladribine—multiple sclerosis	0.000746	0.00223	CcSEcCtD
Candesartan—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000745	0.00223	CcSEcCtD
Candesartan—Haemorrhage—Betamethasone—multiple sclerosis	0.000743	0.00222	CcSEcCtD
Candesartan—Haemorrhage—Dexamethasone—multiple sclerosis	0.000743	0.00222	CcSEcCtD
Candesartan—Rash—Cladribine—multiple sclerosis	0.00074	0.00221	CcSEcCtD
Candesartan—Dermatitis—Cladribine—multiple sclerosis	0.000739	0.00221	CcSEcCtD
Candesartan—Headache—Cladribine—multiple sclerosis	0.000735	0.0022	CcSEcCtD
Candesartan—Hyperglycaemia—Prednisone—multiple sclerosis	0.000729	0.00218	CcSEcCtD
Candesartan—Hypotension—Mitoxantrone—multiple sclerosis	0.000721	0.00216	CcSEcCtD
Candesartan—Mental disorder—Methylprednisolone—multiple sclerosis	0.000716	0.00214	CcSEcCtD
Candesartan—Malnutrition—Methylprednisolone—multiple sclerosis	0.000711	0.00213	CcSEcCtD
Candesartan—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000711	0.00213	CcSEcCtD
Candesartan—Angioedema—Prednisolone—multiple sclerosis	0.000708	0.00212	CcSEcCtD
Candesartan—Myocardial infarction—Prednisone—multiple sclerosis	0.000707	0.00211	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000703	0.0021	CcSEcCtD
Candesartan—Nausea—Cladribine—multiple sclerosis	0.000697	0.00208	CcSEcCtD
Candesartan—Vertigo—Prednisolone—multiple sclerosis	0.000696	0.00208	CcSEcCtD
Candesartan—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000692	0.00207	CcSEcCtD
Candesartan—Back pain—Triamcinolone—multiple sclerosis	0.000689	0.00206	CcSEcCtD
Candesartan—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000687	0.00206	CcSEcCtD
Candesartan—Somnolence—Mitoxantrone—multiple sclerosis	0.000685	0.00205	CcSEcCtD
Candesartan—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000679	0.00203	CcSEcCtD
Candesartan—Hypertension—Prednisolone—multiple sclerosis	0.000669	0.002	CcSEcCtD
Candesartan—Fatigue—Mitoxantrone—multiple sclerosis	0.000665	0.00199	CcSEcCtD
Candesartan—Diarrhoea—Azathioprine—multiple sclerosis	0.000653	0.00195	CcSEcCtD
Candesartan—Angioedema—Triamcinolone—multiple sclerosis	0.000651	0.00195	CcSEcCtD
Candesartan—Haemoglobin—Prednisone—multiple sclerosis	0.00065	0.00195	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00065	0.00471	CbGpPWpGaD
Candesartan—Angioedema—Methylprednisolone—multiple sclerosis	0.00065	0.00194	CcSEcCtD
Candesartan—Haemorrhage—Prednisone—multiple sclerosis	0.000647	0.00194	CcSEcCtD
Candesartan—Losartan—ALB—multiple sclerosis	0.000647	0.111	CrCbGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCR3—multiple sclerosis	0.000642	0.00465	CbGpPWpGaD
Candesartan—Vertigo—Triamcinolone—multiple sclerosis	0.00064	0.00192	CcSEcCtD
Candesartan—Vertigo—Methylprednisolone—multiple sclerosis	0.000639	0.00191	CcSEcCtD
Candesartan—Neutropenia—Methotrexate—multiple sclerosis	0.000632	0.00189	CcSEcCtD
Candesartan—Dizziness—Azathioprine—multiple sclerosis	0.000631	0.00189	CcSEcCtD
Candesartan—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000631	0.00189	CcSEcCtD
Candesartan—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000628	0.00188	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCR2—multiple sclerosis	0.000625	0.00453	CbGpPWpGaD
Candesartan—Cough—Triamcinolone—multiple sclerosis	0.000622	0.00186	CcSEcCtD
Candesartan—Tachycardia—Prednisolone—multiple sclerosis	0.000617	0.00185	CcSEcCtD
Candesartan—Hypertension—Triamcinolone—multiple sclerosis	0.000615	0.00184	CcSEcCtD
Candesartan—Hypertension—Methylprednisolone—multiple sclerosis	0.000614	0.00184	CcSEcCtD
Candesartan—Urticaria—Mitoxantrone—multiple sclerosis	0.000613	0.00183	CcSEcCtD
Candesartan—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000612	0.00183	CcSEcCtD
Candesartan—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00061	0.00182	CcSEcCtD
Candesartan—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00061	0.00182	CcSEcCtD
Candesartan—Myalgia—Triamcinolone—multiple sclerosis	0.000607	0.00182	CcSEcCtD
Candesartan—Vomiting—Azathioprine—multiple sclerosis	0.000606	0.00181	CcSEcCtD
Candesartan—Myalgia—Methylprednisolone—multiple sclerosis	0.000606	0.00181	CcSEcCtD
Candesartan—Arthralgia—Methylprednisolone—multiple sclerosis	0.000606	0.00181	CcSEcCtD
Candesartan—Anxiety—Methylprednisolone—multiple sclerosis	0.000603	0.00181	CcSEcCtD
Candesartan—Rash—Azathioprine—multiple sclerosis	0.000601	0.0018	CcSEcCtD
Candesartan—Dermatitis—Azathioprine—multiple sclerosis	0.000601	0.0018	CcSEcCtD
Candesartan—Headache—Azathioprine—multiple sclerosis	0.000598	0.00179	CcSEcCtD
Candesartan—Renal failure—Methotrexate—multiple sclerosis	0.000592	0.00177	CcSEcCtD
Candesartan—Angioedema—Betamethasone—multiple sclerosis	0.000591	0.00177	CcSEcCtD
Candesartan—Angioedema—Dexamethasone—multiple sclerosis	0.000591	0.00177	CcSEcCtD
Candesartan—Vertigo—Betamethasone—multiple sclerosis	0.000581	0.00174	CcSEcCtD
Candesartan—Vertigo—Dexamethasone—multiple sclerosis	0.000581	0.00174	CcSEcCtD
Candesartan—Haematuria—Methotrexate—multiple sclerosis	0.000574	0.00172	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000574	0.00416	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000574	0.00416	CbGpPWpGaD
Candesartan—Epistaxis—Methotrexate—multiple sclerosis	0.000568	0.0017	CcSEcCtD
Candesartan—Paraesthesia—Prednisolone—multiple sclerosis	0.000568	0.0017	CcSEcCtD
Candesartan—Tachycardia—Triamcinolone—multiple sclerosis	0.000568	0.0017	CcSEcCtD
Candesartan—Mental disorder—Prednisone—multiple sclerosis	0.000567	0.0017	CcSEcCtD
Candesartan—Nausea—Azathioprine—multiple sclerosis	0.000567	0.00169	CcSEcCtD
Candesartan—Tachycardia—Methylprednisolone—multiple sclerosis	0.000567	0.00169	CcSEcCtD
Candesartan—Malnutrition—Prednisone—multiple sclerosis	0.000563	0.00168	CcSEcCtD
Candesartan—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000562	0.00168	CcSEcCtD
Candesartan—Agranulocytosis—Methotrexate—multiple sclerosis	0.000562	0.00168	CcSEcCtD
Candesartan—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000561	0.00168	CcSEcCtD
Candesartan—Hypertension—Dexamethasone—multiple sclerosis	0.000558	0.00167	CcSEcCtD
Candesartan—Hypertension—Betamethasone—multiple sclerosis	0.000558	0.00167	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	0.000558	0.00404	CbGpPWpGaD
Candesartan—Asthenia—Mitoxantrone—multiple sclerosis	0.000553	0.00165	CcSEcCtD
Candesartan—Myalgia—Betamethasone—multiple sclerosis	0.000551	0.00165	CcSEcCtD
Candesartan—Myalgia—Dexamethasone—multiple sclerosis	0.000551	0.00165	CcSEcCtD
Candesartan—Anxiety—Dexamethasone—multiple sclerosis	0.000549	0.00164	CcSEcCtD
Candesartan—Anxiety—Betamethasone—multiple sclerosis	0.000549	0.00164	CcSEcCtD
Candesartan—Haemoglobin—Methotrexate—multiple sclerosis	0.000543	0.00163	CcSEcCtD
Candesartan—Hypotension—Methylprednisolone—multiple sclerosis	0.000542	0.00162	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—GPR65—multiple sclerosis	0.000541	0.00392	CbGpPWpGaD
Candesartan—Haemorrhage—Methotrexate—multiple sclerosis	0.000541	0.00162	CcSEcCtD
Candesartan—Hepatitis—Methotrexate—multiple sclerosis	0.000541	0.00162	CcSEcCtD
Candesartan—Pharyngitis—Methotrexate—multiple sclerosis	0.000537	0.00161	CcSEcCtD
Candesartan—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000534	0.0016	CcSEcCtD
Candesartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000532	0.00385	CbGpPWpGaD
Candesartan—Urethral disorder—Methotrexate—multiple sclerosis	0.00053	0.00159	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00053	0.00159	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000529	0.00158	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IFNG—multiple sclerosis	0.000528	0.00383	CbGpPWpGaD
Candesartan—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000528	0.00158	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000523	0.00378	CbGpPWpGaD
Candesartan—Paraesthesia—Triamcinolone—multiple sclerosis	0.000522	0.00156	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000522	0.00378	CbGpPWpGaD
Candesartan—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000521	0.00156	CcSEcCtD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000521	0.00377	CbGpPWpGaD
Candesartan—Anaemia—Prednisone—multiple sclerosis	0.000521	0.00156	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.000519	0.00376	CbGpPWpGaD
Candesartan—Dyspnoea—Triamcinolone—multiple sclerosis	0.000519	0.00155	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK1—multiple sclerosis	0.000518	0.00375	CbGpPWpGaD
Candesartan—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000517	0.00155	CcSEcCtD
Candesartan—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000517	0.00155	CcSEcCtD
Candesartan—Tachycardia—Betamethasone—multiple sclerosis	0.000515	0.00154	CcSEcCtD
Candesartan—Tachycardia—Dexamethasone—multiple sclerosis	0.000515	0.00154	CcSEcCtD
Candesartan—Angioedema—Prednisone—multiple sclerosis	0.000515	0.00154	CcSEcCtD
Candesartan—Dyspepsia—Triamcinolone—multiple sclerosis	0.000512	0.00153	CcSEcCtD
Candesartan—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000511	0.00153	CcSEcCtD
Candesartan—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00051	0.00153	CcSEcCtD
Candesartan—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00051	0.00153	CcSEcCtD
Candesartan—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.00051	0.0037	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.00051	0.0037	CbGpPWpGaD
Candesartan—Vertigo—Prednisone—multiple sclerosis	0.000506	0.00151	CcSEcCtD
Candesartan—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000503	0.00364	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000503	0.00364	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000503	0.00364	CbGpPWpGaD
Candesartan—Urticaria—Prednisolone—multiple sclerosis	0.000503	0.0015	CcSEcCtD
Candesartan—Fatigue—Triamcinolone—multiple sclerosis	0.000502	0.0015	CcSEcCtD
Candesartan—Fatigue—Methylprednisolone—multiple sclerosis	0.0005	0.0015	CcSEcCtD
Candesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000497	0.0036	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCL13—multiple sclerosis	0.000495	0.00359	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCR1—multiple sclerosis	0.000495	0.00359	CbGpPWpGaD
Candesartan—Hypotension—Dexamethasone—multiple sclerosis	0.000493	0.00148	CcSEcCtD
Candesartan—Hypotension—Betamethasone—multiple sclerosis	0.000493	0.00148	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—multiple sclerosis	0.000493	0.00357	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000493	0.00357	CbGpPWpGaD
Candesartan—Vomiting—Mitoxantrone—multiple sclerosis	0.00049	0.00147	CcSEcCtD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000489	0.00354	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000488	0.00353	CbGpPWpGaD
Candesartan—Hypertension—Prednisone—multiple sclerosis	0.000486	0.00145	CcSEcCtD
Candesartan—Rash—Mitoxantrone—multiple sclerosis	0.000486	0.00145	CcSEcCtD
Candesartan—Dermatitis—Mitoxantrone—multiple sclerosis	0.000486	0.00145	CcSEcCtD
Candesartan—Headache—Mitoxantrone—multiple sclerosis	0.000483	0.00145	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000481	0.00144	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000481	0.00144	CcSEcCtD
Candesartan—Myalgia—Prednisone—multiple sclerosis	0.00048	0.00143	CcSEcCtD
Candesartan—Arthralgia—Prednisone—multiple sclerosis	0.00048	0.00143	CcSEcCtD
Candesartan—Anxiety—Prednisone—multiple sclerosis	0.000478	0.00143	CcSEcCtD
Candesartan—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000475	0.00142	CcSEcCtD
Candesartan—Paraesthesia—Dexamethasone—multiple sclerosis	0.000474	0.00142	CcSEcCtD
Candesartan—Paraesthesia—Betamethasone—multiple sclerosis	0.000474	0.00142	CcSEcCtD
Candesartan—Mental disorder—Methotrexate—multiple sclerosis	0.000474	0.00142	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IL1B—multiple sclerosis	0.000471	0.00341	CbGpPWpGaD
Candesartan—Malnutrition—Methotrexate—multiple sclerosis	0.000471	0.00141	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IL2—multiple sclerosis	0.000469	0.0034	CbGpPWpGaD
Candesartan—Dyspepsia—Betamethasone—multiple sclerosis	0.000465	0.00139	CcSEcCtD
Candesartan—Dyspepsia—Dexamethasone—multiple sclerosis	0.000465	0.00139	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000463	0.00336	CbGpPWpGaD
Candesartan—Urticaria—Triamcinolone—multiple sclerosis	0.000462	0.00138	CcSEcCtD
Candesartan—Urticaria—Methylprednisolone—multiple sclerosis	0.000461	0.00138	CcSEcCtD
Candesartan—Body temperature increased—Triamcinolone—multiple sclerosis	0.00046	0.00138	CcSEcCtD
Candesartan—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000459	0.00137	CcSEcCtD
Candesartan—Nausea—Mitoxantrone—multiple sclerosis	0.000458	0.00137	CcSEcCtD
Candesartan—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000456	0.00136	CcSEcCtD
Candesartan—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000456	0.00136	CcSEcCtD
Candesartan—Back pain—Methotrexate—multiple sclerosis	0.000455	0.00136	CcSEcCtD
Candesartan—Fatigue—Betamethasone—multiple sclerosis	0.000455	0.00136	CcSEcCtD
Candesartan—Fatigue—Dexamethasone—multiple sclerosis	0.000455	0.00136	CcSEcCtD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000451	0.00327	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	0.00045	0.00326	CbGpPWpGaD
Candesartan—Tachycardia—Prednisone—multiple sclerosis	0.000449	0.00134	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000447	0.00324	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.000447	0.00324	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000446	0.00323	CbGpPWpGaD
Candesartan—Hyperhidrosis—Prednisone—multiple sclerosis	0.000444	0.00133	CcSEcCtD
Candesartan—Anaemia—Methotrexate—multiple sclerosis	0.000435	0.0013	CcSEcCtD
Candesartan—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000432	0.00129	CcSEcCtD
Candesartan—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000432	0.00129	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000431	0.00312	CbGpPWpGaD
Candesartan—Vertigo—Methotrexate—multiple sclerosis	0.000423	0.00127	CcSEcCtD
Candesartan—Leukopenia—Methotrexate—multiple sclerosis	0.000421	0.00126	CcSEcCtD
Candesartan—Urticaria—Betamethasone—multiple sclerosis	0.000419	0.00125	CcSEcCtD
Candesartan—Urticaria—Dexamethasone—multiple sclerosis	0.000419	0.00125	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000419	0.00304	CbGpPWpGaD
Candesartan—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000419	0.00125	CcSEcCtD
Candesartan—Dizziness—Prednisolone—multiple sclerosis	0.000418	0.00125	CcSEcCtD
Candesartan—Asthenia—Triamcinolone—multiple sclerosis	0.000417	0.00125	CcSEcCtD
Candesartan—Body temperature increased—Dexamethasone—multiple sclerosis	0.000417	0.00125	CcSEcCtD
Candesartan—Body temperature increased—Betamethasone—multiple sclerosis	0.000417	0.00125	CcSEcCtD
Candesartan—Abdominal pain—Betamethasone—multiple sclerosis	0.000417	0.00125	CcSEcCtD
Candesartan—Abdominal pain—Dexamethasone—multiple sclerosis	0.000417	0.00125	CcSEcCtD
Candesartan—Asthenia—Methylprednisolone—multiple sclerosis	0.000416	0.00125	CcSEcCtD
Candesartan—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000415	0.00301	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000415	0.00301	CbGpPWpGaD
Candesartan—Paraesthesia—Prednisone—multiple sclerosis	0.000413	0.00123	CcSEcCtD
Candesartan—Pruritus—Triamcinolone—multiple sclerosis	0.000412	0.00123	CcSEcCtD
Candesartan—Cough—Methotrexate—multiple sclerosis	0.000411	0.00123	CcSEcCtD
Candesartan—Pruritus—Methylprednisolone—multiple sclerosis	0.000411	0.00123	CcSEcCtD
Candesartan—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00041	0.00297	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00041	0.00297	CbGpPWpGaD
Candesartan—Dyspepsia—Prednisone—multiple sclerosis	0.000405	0.00121	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.000403	0.00292	CbGpPWpGaD
Candesartan—Myalgia—Methotrexate—multiple sclerosis	0.000401	0.0012	CcSEcCtD
Candesartan—Chest pain—Methotrexate—multiple sclerosis	0.000401	0.0012	CcSEcCtD
Candesartan—Arthralgia—Methotrexate—multiple sclerosis	0.000401	0.0012	CcSEcCtD
Candesartan—Rash—Prednisolone—multiple sclerosis	0.000399	0.00119	CcSEcCtD
Candesartan—Dermatitis—Prednisolone—multiple sclerosis	0.000398	0.00119	CcSEcCtD
Candesartan—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000397	0.00119	CcSEcCtD
Candesartan—Fatigue—Prednisone—multiple sclerosis	0.000396	0.00119	CcSEcCtD
Candesartan—Headache—Prednisolone—multiple sclerosis	0.000396	0.00119	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000388	0.00281	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000387	0.0028	CbGpPWpGaD
Candesartan—Dizziness—Triamcinolone—multiple sclerosis	0.000385	0.00115	CcSEcCtD
Candesartan—Dizziness—Methylprednisolone—multiple sclerosis	0.000384	0.00115	CcSEcCtD
Candesartan—AGTR1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00038	0.00275	CbGpPWpGaD
Candesartan—Asthenia—Betamethasone—multiple sclerosis	0.000379	0.00113	CcSEcCtD
Candesartan—Asthenia—Dexamethasone—multiple sclerosis	0.000379	0.00113	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000377	0.00273	CbGpPWpGaD
Candesartan—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000376	0.00113	CcSEcCtD
Candesartan—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000376	0.00112	CcSEcCtD
Candesartan—Nausea—Prednisolone—multiple sclerosis	0.000376	0.00112	CcSEcCtD
Candesartan—Pruritus—Betamethasone—multiple sclerosis	0.000373	0.00112	CcSEcCtD
Candesartan—Pruritus—Dexamethasone—multiple sclerosis	0.000373	0.00112	CcSEcCtD
Candesartan—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000371	0.00111	CcSEcCtD
Candesartan—Vomiting—Triamcinolone—multiple sclerosis	0.00037	0.00111	CcSEcCtD
Candesartan—Vomiting—Methylprednisolone—multiple sclerosis	0.000369	0.0011	CcSEcCtD
Candesartan—Rash—Triamcinolone—multiple sclerosis	0.000367	0.0011	CcSEcCtD
Candesartan—Dermatitis—Triamcinolone—multiple sclerosis	0.000366	0.0011	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—TGFB1—multiple sclerosis	0.000366	0.00265	CbGpPWpGaD
Candesartan—Rash—Methylprednisolone—multiple sclerosis	0.000366	0.00109	CcSEcCtD
Candesartan—Dermatitis—Methylprednisolone—multiple sclerosis	0.000366	0.00109	CcSEcCtD
Candesartan—Urticaria—Prednisone—multiple sclerosis	0.000365	0.00109	CcSEcCtD
Candesartan—Headache—Triamcinolone—multiple sclerosis	0.000364	0.00109	CcSEcCtD
Candesartan—Headache—Methylprednisolone—multiple sclerosis	0.000364	0.00109	CcSEcCtD
Candesartan—Abdominal pain—Prednisone—multiple sclerosis	0.000363	0.00109	CcSEcCtD
Candesartan—Body temperature increased—Prednisone—multiple sclerosis	0.000363	0.00109	CcSEcCtD
Candesartan—Diarrhoea—Betamethasone—multiple sclerosis	0.000361	0.00108	CcSEcCtD
Candesartan—Diarrhoea—Dexamethasone—multiple sclerosis	0.000361	0.00108	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000361	0.00261	CbGpPWpGaD
Candesartan—Hypotension—Methotrexate—multiple sclerosis	0.000359	0.00107	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000358	0.00259	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCL3—multiple sclerosis	0.000353	0.00256	CbGpPWpGaD
Candesartan—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00035	0.00105	CcSEcCtD
Candesartan—Dizziness—Dexamethasone—multiple sclerosis	0.000349	0.00104	CcSEcCtD
Candesartan—Dizziness—Betamethasone—multiple sclerosis	0.000349	0.00104	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000348	0.00252	CbGpPWpGaD
Candesartan—Nausea—Triamcinolone—multiple sclerosis	0.000346	0.00103	CcSEcCtD
Candesartan—Paraesthesia—Methotrexate—multiple sclerosis	0.000345	0.00103	CcSEcCtD
Candesartan—Nausea—Methylprednisolone—multiple sclerosis	0.000345	0.00103	CcSEcCtD
Candesartan—AGTR1—Signaling by GPCR—S1PR1—multiple sclerosis	0.000345	0.0025	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000344	0.00249	CbGpPWpGaD
Candesartan—Dyspnoea—Methotrexate—multiple sclerosis	0.000343	0.00102	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—TNF—multiple sclerosis	0.000342	0.00248	CbGpPWpGaD
Candesartan—Somnolence—Methotrexate—multiple sclerosis	0.000342	0.00102	CcSEcCtD
Candesartan—UGT1A3—Metabolism—SRM—multiple sclerosis	0.00034	0.00247	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—PTGER4—multiple sclerosis	0.00034	0.00246	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000339	0.00246	CbGpPWpGaD
Candesartan—Dyspepsia—Methotrexate—multiple sclerosis	0.000338	0.00101	CcSEcCtD
Candesartan—Vomiting—Betamethasone—multiple sclerosis	0.000336	0.001	CcSEcCtD
Candesartan—Vomiting—Dexamethasone—multiple sclerosis	0.000336	0.001	CcSEcCtD
Candesartan—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000335	0.00242	CbGpPWpGaD
Candesartan—Rash—Betamethasone—multiple sclerosis	0.000333	0.000996	CcSEcCtD
Candesartan—Rash—Dexamethasone—multiple sclerosis	0.000333	0.000996	CcSEcCtD
Candesartan—Dermatitis—Betamethasone—multiple sclerosis	0.000333	0.000995	CcSEcCtD
Candesartan—Dermatitis—Dexamethasone—multiple sclerosis	0.000333	0.000995	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000332	0.00241	CbGpPWpGaD
Candesartan—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000332	0.000992	CcSEcCtD
Candesartan—Fatigue—Methotrexate—multiple sclerosis	0.000331	0.000991	CcSEcCtD
Candesartan—Headache—Betamethasone—multiple sclerosis	0.000331	0.000989	CcSEcCtD
Candesartan—Headache—Dexamethasone—multiple sclerosis	0.000331	0.000989	CcSEcCtD
Candesartan—Asthenia—Prednisone—multiple sclerosis	0.00033	0.000987	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000328	0.00238	CbGpPWpGaD
Candesartan—Pruritus—Prednisone—multiple sclerosis	0.000325	0.000973	CcSEcCtD
Candesartan—AGTR1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000323	0.00234	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCR2—multiple sclerosis	0.000319	0.00231	CbGpPWpGaD
Candesartan—UGT1A3—Biological oxidations—POMC—multiple sclerosis	0.000315	0.00229	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000315	0.00228	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000315	0.00228	CbGpPWpGaD
Candesartan—Diarrhoea—Prednisone—multiple sclerosis	0.000315	0.000941	CcSEcCtD
Candesartan—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000314	0.00094	CcSEcCtD
Candesartan—Nausea—Dexamethasone—multiple sclerosis	0.000314	0.000938	CcSEcCtD
Candesartan—Nausea—Betamethasone—multiple sclerosis	0.000314	0.000938	CcSEcCtD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.00031	0.00224	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000308	0.00223	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000306	0.00222	CbGpPWpGaD
Candesartan—Urticaria—Methotrexate—multiple sclerosis	0.000305	0.000913	CcSEcCtD
Candesartan—Dizziness—Prednisone—multiple sclerosis	0.000304	0.000909	CcSEcCtD
Candesartan—Body temperature increased—Methotrexate—multiple sclerosis	0.000304	0.000908	CcSEcCtD
Candesartan—Abdominal pain—Methotrexate—multiple sclerosis	0.000304	0.000908	CcSEcCtD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000303	0.0022	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000303	0.0022	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.0003	0.00217	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000298	0.00216	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000297	0.00215	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CNR1—multiple sclerosis	0.000294	0.00213	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—RGS1—multiple sclerosis	0.000293	0.00212	CbGpPWpGaD
Candesartan—Vomiting—Prednisone—multiple sclerosis	0.000292	0.000874	CcSEcCtD
Candesartan—Rash—Prednisone—multiple sclerosis	0.00029	0.000867	CcSEcCtD
Candesartan—Dermatitis—Prednisone—multiple sclerosis	0.00029	0.000866	CcSEcCtD
Candesartan—Headache—Prednisone—multiple sclerosis	0.000288	0.000861	CcSEcCtD
Candesartan—AGTR1—GPCR downstream signaling—CCR1—multiple sclerosis	0.00028	0.00203	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00028	0.00203	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000279	0.00202	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—GPR65—multiple sclerosis	0.000278	0.00201	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000277	0.00201	CbGpPWpGaD
Candesartan—Asthenia—Methotrexate—multiple sclerosis	0.000276	0.000825	CcSEcCtD
Candesartan—Nausea—Prednisone—multiple sclerosis	0.000273	0.000817	CcSEcCtD
Candesartan—Pruritus—Methotrexate—multiple sclerosis	0.000272	0.000813	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00027	0.00196	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000269	0.00195	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LINGO1—multiple sclerosis	0.000269	0.00195	CbGpPWpGaD
Candesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000267	0.00193	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000265	0.00192	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000264	0.00191	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000264	0.00191	CbGpPWpGaD
Candesartan—Diarrhoea—Methotrexate—multiple sclerosis	0.000263	0.000786	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000256	0.00186	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCR1—multiple sclerosis	0.000254	0.00184	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000254	0.00184	CbGpPWpGaD
Candesartan—Dizziness—Methotrexate—multiple sclerosis	0.000254	0.00076	CcSEcCtD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000253	0.00183	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000253	0.00183	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000251	0.00182	CbGpPWpGaD
Candesartan—Vomiting—Methotrexate—multiple sclerosis	0.000244	0.000731	CcSEcCtD
Candesartan—Rash—Methotrexate—multiple sclerosis	0.000242	0.000725	CcSEcCtD
Candesartan—Dermatitis—Methotrexate—multiple sclerosis	0.000242	0.000724	CcSEcCtD
Candesartan—Headache—Methotrexate—multiple sclerosis	0.000241	0.00072	CcSEcCtD
Candesartan—UGT1A3—Metabolism—CYP27B1—multiple sclerosis	0.00024	0.00174	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYP24A1—multiple sclerosis	0.00024	0.00174	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—FAS—multiple sclerosis	0.000236	0.00171	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	0.000235	0.0017	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TAGAP—multiple sclerosis	0.000233	0.00169	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	0.000232	0.00168	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCL5—multiple sclerosis	0.000228	0.00165	CbGpPWpGaD
Candesartan—Nausea—Methotrexate—multiple sclerosis	0.000228	0.000683	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000225	0.00163	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GPC5—multiple sclerosis	0.000219	0.00159	CbGpPWpGaD
Candesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000217	0.00157	CbGpPWpGaD
Candesartan—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000216	0.00157	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	0.000212	0.00154	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000211	0.00153	CbGpPWpGaD
Candesartan—UGT1A3—NRF2 pathway—TGFB1—multiple sclerosis	0.000207	0.0015	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000206	0.0015	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCR5—multiple sclerosis	0.000206	0.00149	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—S1PR1—multiple sclerosis	0.000204	0.00147	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GPC5—multiple sclerosis	0.000198	0.00143	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CD80—multiple sclerosis	0.000196	0.00142	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000196	0.00142	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000196	0.00142	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000192	0.00139	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SRM—multiple sclerosis	0.000192	0.00139	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000185	0.00134	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—RRM1—multiple sclerosis	0.000182	0.00132	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL3—multiple sclerosis	0.000181	0.00131	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CCR2—multiple sclerosis	0.00018	0.00131	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—POMC—multiple sclerosis	0.000178	0.00129	CbGpPWpGaD
Candesartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000176	0.00127	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000175	0.00126	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000174	0.00126	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RGS1—multiple sclerosis	0.000173	0.00125	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.00017	0.00123	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000168	0.00122	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000166	0.00121	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GPR65—multiple sclerosis	0.000164	0.00119	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCR2—multiple sclerosis	0.000164	0.00119	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	0.000164	0.00118	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000161	0.00117	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—POMC—multiple sclerosis	0.000161	0.00116	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000159	0.00116	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000159	0.00116	CbGpPWpGaD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	0.000158	0.00114	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCL2—multiple sclerosis	0.000157	0.00114	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	0.000155	0.00112	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CNR1—multiple sclerosis	0.000151	0.00109	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL13—multiple sclerosis	0.00015	0.00109	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCR1—multiple sclerosis	0.00015	0.00109	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00015	0.00109	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	0.000138	0.001	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL2—multiple sclerosis	0.000138	0.000998	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000136	0.000987	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000136	0.000986	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP27B1—multiple sclerosis	0.000135	0.000978	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP24A1—multiple sclerosis	0.000135	0.000978	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000132	0.000958	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000132	0.000956	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000132	0.000956	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000129	0.000934	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SRM—multiple sclerosis	0.000124	0.000897	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000124	0.000897	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GPC5—multiple sclerosis	0.000124	0.000895	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL5—multiple sclerosis	0.000117	0.000848	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000117	0.000845	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000116	0.000842	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—POMC—multiple sclerosis	0.000115	0.000831	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000115	0.00083	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SRM—multiple sclerosis	0.000108	0.000782	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	0.000107	0.000778	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL3—multiple sclerosis	0.000107	0.000775	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCR5—multiple sclerosis	0.000106	0.000764	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000105	0.000758	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—BCHE—multiple sclerosis	0.000104	0.000756	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000104	0.000753	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTGER4—multiple sclerosis	0.000103	0.000746	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—RRM1—multiple sclerosis	0.000102	0.000742	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PGR—multiple sclerosis	0.000101	0.000734	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SRM—multiple sclerosis	0.000101	0.00073	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TNF—multiple sclerosis	0.0001	0.000727	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCR3—multiple sclerosis	9.94e-05	0.00072	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CD28—multiple sclerosis	9.85e-05	0.000714	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCR2—multiple sclerosis	9.67e-05	0.000701	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—POMC—multiple sclerosis	9.34e-05	0.000677	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.25e-05	0.00067	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—POMC—multiple sclerosis	9.08e-05	0.000658	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CNR1—multiple sclerosis	8.93e-05	0.000647	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	8.73e-05	0.000632	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	8.73e-05	0.000632	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.53e-05	0.000618	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—POMC—multiple sclerosis	8.25e-05	0.000597	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL2—multiple sclerosis	8.07e-05	0.000584	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL10—multiple sclerosis	8.04e-05	0.000582	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GPC5—multiple sclerosis	7.98e-05	0.000578	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.94e-05	0.000575	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP27B1—multiple sclerosis	7.6e-05	0.000551	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP24A1—multiple sclerosis	7.6e-05	0.000551	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—TYK2—multiple sclerosis	7.33e-05	0.000531	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	7.1e-05	0.000514	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	7.1e-05	0.000514	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CD86—multiple sclerosis	7.03e-05	0.000509	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPC5—multiple sclerosis	6.95e-05	0.000504	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.94e-05	0.000503	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL5—multiple sclerosis	6.92e-05	0.000501	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.82e-05	0.000494	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL2—multiple sclerosis	6.71e-05	0.000486	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—RRM1—multiple sclerosis	6.61e-05	0.000479	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPC5—multiple sclerosis	6.5e-05	0.00047	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SPP1—multiple sclerosis	6.41e-05	0.000464	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—APOE—multiple sclerosis	6.28e-05	0.000455	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCR5—multiple sclerosis	6.23e-05	0.000452	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.22e-05	0.000451	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2RA—multiple sclerosis	6.14e-05	0.000445	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL2—multiple sclerosis	6.1e-05	0.000442	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—BCHE—multiple sclerosis	5.88e-05	0.000426	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—RRM1—multiple sclerosis	5.76e-05	0.000417	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APOE—multiple sclerosis	5.67e-05	0.000411	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—POMC—multiple sclerosis	5.4e-05	0.000391	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—RRM1—multiple sclerosis	5.38e-05	0.00039	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.32e-05	0.000385	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.3e-05	0.000384	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.2e-05	0.000377	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.13e-05	0.000372	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CD80—multiple sclerosis	5.13e-05	0.000371	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.95e-05	0.000359	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALB—multiple sclerosis	4.92e-05	0.000356	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—POMC—multiple sclerosis	4.87e-05	0.000353	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL2—multiple sclerosis	4.77e-05	0.000345	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—MAPK1—multiple sclerosis	4.66e-05	0.000338	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.41e-05	0.000319	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TYK2—multiple sclerosis	4.33e-05	0.000314	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.18e-05	0.000302	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.02e-05	0.000291	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—BCHE—multiple sclerosis	3.8e-05	0.000275	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2—multiple sclerosis	3.6e-05	0.000261	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.59e-05	0.00026	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—multiple sclerosis	3.58e-05	0.00026	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOE—multiple sclerosis	3.54e-05	0.000256	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—multiple sclerosis	3.41e-05	0.000247	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.33e-05	0.000241	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—BCHE—multiple sclerosis	3.31e-05	0.00024	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.27e-05	0.000237	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—BCHE—multiple sclerosis	3.09e-05	0.000224	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—POMC—multiple sclerosis	3.04e-05	0.00022	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STAT3—multiple sclerosis	3.03e-05	0.00022	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MYC—multiple sclerosis	2.82e-05	0.000204	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—multiple sclerosis	2.81e-05	0.000203	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—multiple sclerosis	2.77e-05	0.000201	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK1—multiple sclerosis	2.76e-05	0.0002	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOE—multiple sclerosis	2.28e-05	0.000165	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—multiple sclerosis	2.12e-05	0.000153	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOE—multiple sclerosis	1.99e-05	0.000144	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—POMC—multiple sclerosis	1.96e-05	0.000142	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOE—multiple sclerosis	1.86e-05	0.000135	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—multiple sclerosis	1.79e-05	0.00013	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—POMC—multiple sclerosis	1.71e-05	0.000124	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—POMC—multiple sclerosis	1.6e-05	0.000116	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—multiple sclerosis	1.56e-05	0.000113	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—multiple sclerosis	1.46e-05	0.000105	CbGpPWpGaD
